This Kalorama Information report – The World Anesthesia Drug Market - focuses on three primary segments of anesthesia:
The report covers both currently marketed and late stage development anesthesia drugs. For each of these segments the report contains:
Revenues for each segment were generated using dollar and unit sales for each product. Forecasted figures were generated using a combination of projected surgical procedures, patent and exclusivity expirations, pricing trends, new developments and other factors.
The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. Product chapters in this report provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.
There are several issues and trends that are impacting the anesthesia drug market. Many of the issues are centered on safety issues, which are probably one of the most important aspects of the administration of anesthetic agents. This industry is a mature industry so it does not have the typical competitive issues often seen in other pharmaceutical segments. However, there are some issues that concern research and development of promising areas in anesthesia.
Topics included in this section include:
Several hundred companies compete worldwide in the anesthesia drug market. Companies in the market consist of large pharmaceutical companies, niche pain management and anesthesia drug manufacturers, and worldwide generic drug providers.All market data pertains to the world market at the manufacturers’ level. The base year for data was 2011. Historical data was provided for the years 2007 through 2010, with forecast data provided for 2012 through 2016. Compound annual growth rates (CAGRs) are provided for the 2007-2011, 2007-2016 and 2012-2016 periods for each industry segment covered. Competitive analysis is provided for the years 2009-2011. The forecasted market analysis for 2012-2016 was highly influenced by the probability of approval and sales of products in late stage development, product marketing, generic competition, and demographic trends.
The World Anesthesia Drug Market (General, Local, Adjunctive)
Or leave us a message and we'll call you back!
Receive bi-weekly email alerts for new market research.